Public limited company · Mons · incorporated on 05/02/2013 · 0,0 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -4,0 k € | +35.6% | -6,3 k € | — | 0,0 € | +100.0% | -5,3 k € | -121.1% | 24,9 k € | -7.4% | 26,8 k € | +520.7% | -6,4 k € | -71.5% | -3,7 k € | -28.2% | -2,9 k € | +35.9% | -4,5 k € | +53.3% | -9,7 k € | |||
| EBITDA | -5,3 k € | +29.1% | -7,5 k € | -680.0% | -960,3 € | -10.6% | -868,0 € | +85.8% | -6,1 k € | -125.6% | 23,9 k € | -8.0% | 26,0 k € | +458.3% | -7,3 k € | -58.0% | -4,6 k € | -17.1% | -3,9 k € | +19.6% | -4,9 k € | +51.5% | -10,1 k € | |
| Operating profit | -5,3 k € | +29.1% | -7,5 k € | -680.0% | -960,3 € | -10.6% | -868,0 € | +85.8% | -6,1 k € | -125.6% | 23,9 k € | -8.0% | 26,0 k € | +458.3% | -7,3 k € | -58.0% | -4,6 k € | -17.1% | -3,9 k € | +19.6% | -4,9 k € | +51.5% | -10,1 k € | |
| Profit/loss | -42,3 k € | -37.1% | -30,8 k € | -150.4% | -12,3 k € | -11.2% | -11,1 k € | +31.9% | -16,3 k € | -210.4% | 14,7 k € | +43.5% | 10,3 k € | +101.0% | -1,0 M € | -2765.2% | 38,3 k € | +360.8% | -14,7 k € | -108.1% | 181,8 k € | +945.6% | -21,5 k € | |
| Equity | 1,4 M € | -2.9% | 1,5 M € | -2.1% | 1,5 M € | -0.8% | 1,5 M € | -0.7% | 1,5 M € | -0.4% | 1,5 M € | +1.0% | 1,5 M € | +0.7% | 1,5 M € | -30.4% | 2,2 M € | +1.8% | 2,1 M € | +5.4% | 2,0 M € | +18.0% | 1,7 M € | |
| Total assets | 1,9 M € | -0.0% | 1,9 M € | +0.1% | 1,9 M € | -1.9% | 1,9 M € | -0.1% | 1,9 M € | +1.6% | 1,9 M € | -0.1% | 1,9 M € | -0.1% | 1,9 M € | -30.7% | 2,8 M € | +2.9% | 2,7 M € | -0.1% | 2,7 M € | +5.3% | 2,6 M € | |
| Cash | 1,2 k € | -3.0% | 1,2 k € | +1278.9% | 89,7 € | -38.7% | 146,3 € | -87.7% | 1,2 k € | -81.5% | 6,4 k € | -23.6% | 8,4 k € | -23.6% | 11,0 k € | -3.5% | 11,4 k € | -63.9% | 31,6 k € | -16.9% | 38,0 k € | -61.0% | 97,5 k € | |
| Debts | 485,5 k € | +9.5% | 443,3 k € | +8.0% | 410,5 k € | -5.5% | 434,2 k € | +2.3% | 424,4 k € | +9.7% | 387,0 k € | -3.9% | 402,6 k € | -3.0% | 415,0 k € | -31.7% | 607,6 k € | +7.1% | 567,4 k € | -16.6% | 680,1 k € | -20.0% | 850,0 k € | |
| Staff | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | ||||||||||||
Public limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NUTWAY is a Public limited company incorporated in 2013. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Mons.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette